Mutational profile of GNAQQ209 in human tumors

Simona Lamba, Lara Felicioni, Fiamma Buttitta, Fonnet E. Bleeker, Sara Malatesta, Vincenzo Corbo, Aldo Scarpa, Monica Rodolfo, Margaret Knowles, Milo Frattini, Antonio Marchetti, Alberto Bardelli

Research output: Contribution to journalArticle

Abstract

Background: Frequent somatic mutations have recently been identified in the ras-like domain of the heterotrimeric G protein α-subunit (GNAQ) in blue naevi 83%, malignant blue naevi (50%) and ocular melanoma of the uvea (46%). The mutations exclusively affect codon 209 and result in GNAQ constitutive activation which, in turn, acts as a dominant oncogene. Methodology: To assess if the mutations are present in other tumor types we performed a systematic mutational profile of the GNAQ exon 5 in a panel of 922 neoplasms, including glioblastoma, gastrointestinal stromal tumors (GIST), acute myeloid leukemia (AML), blue naevi, skin melanoma, bladder, breast, colorectal, lung, ovarian, pancreas, and thyroid carcinomas. Principal Findings: We detected the previously reported mutations in 6/ 13 (46%) blue naevi. Changes affecting Q209 were not found in any of the other tumors. Our data indicate that the occurrence of GNAQ mutations display a unique pattern being present in a subset of melanocytic tumors but not in malignancies of glial, epithelial and stromal origin analyzed in this study.

Original languageEnglish
Article numbere6833
JournalPLoS One
Volume4
Issue number8
DOIs
Publication statusPublished - Aug 31 2009

Fingerprint

Blue Nevus
Tumors
Mutation
neoplasms
mutation
Neoplasms
melanoma
Heterotrimeric GTP-Binding Proteins
Nevi and Melanomas
Protein Subunits
somatic mutation
myeloid leukemia
Gastrointestinal Stromal Tumors
oncogenes
neuroglia
Exons
protein subunits
Glioblastoma
Skin
G-proteins

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Lamba, S., Felicioni, L., Buttitta, F., Bleeker, F. E., Malatesta, S., Corbo, V., ... Bardelli, A. (2009). Mutational profile of GNAQQ209 in human tumors. PLoS One, 4(8), [e6833]. https://doi.org/10.1371/journal.pone.0006833

Mutational profile of GNAQQ209 in human tumors. / Lamba, Simona; Felicioni, Lara; Buttitta, Fiamma; Bleeker, Fonnet E.; Malatesta, Sara; Corbo, Vincenzo; Scarpa, Aldo; Rodolfo, Monica; Knowles, Margaret; Frattini, Milo; Marchetti, Antonio; Bardelli, Alberto.

In: PLoS One, Vol. 4, No. 8, e6833, 31.08.2009.

Research output: Contribution to journalArticle

Lamba, S, Felicioni, L, Buttitta, F, Bleeker, FE, Malatesta, S, Corbo, V, Scarpa, A, Rodolfo, M, Knowles, M, Frattini, M, Marchetti, A & Bardelli, A 2009, 'Mutational profile of GNAQQ209 in human tumors', PLoS One, vol. 4, no. 8, e6833. https://doi.org/10.1371/journal.pone.0006833
Lamba S, Felicioni L, Buttitta F, Bleeker FE, Malatesta S, Corbo V et al. Mutational profile of GNAQQ209 in human tumors. PLoS One. 2009 Aug 31;4(8). e6833. https://doi.org/10.1371/journal.pone.0006833
Lamba, Simona ; Felicioni, Lara ; Buttitta, Fiamma ; Bleeker, Fonnet E. ; Malatesta, Sara ; Corbo, Vincenzo ; Scarpa, Aldo ; Rodolfo, Monica ; Knowles, Margaret ; Frattini, Milo ; Marchetti, Antonio ; Bardelli, Alberto. / Mutational profile of GNAQQ209 in human tumors. In: PLoS One. 2009 ; Vol. 4, No. 8.
@article{f51fe6b78c4542a28989a4ae9a3e425c,
title = "Mutational profile of GNAQQ209 in human tumors",
abstract = "Background: Frequent somatic mutations have recently been identified in the ras-like domain of the heterotrimeric G protein α-subunit (GNAQ) in blue naevi 83{\%}, malignant blue naevi (50{\%}) and ocular melanoma of the uvea (46{\%}). The mutations exclusively affect codon 209 and result in GNAQ constitutive activation which, in turn, acts as a dominant oncogene. Methodology: To assess if the mutations are present in other tumor types we performed a systematic mutational profile of the GNAQ exon 5 in a panel of 922 neoplasms, including glioblastoma, gastrointestinal stromal tumors (GIST), acute myeloid leukemia (AML), blue naevi, skin melanoma, bladder, breast, colorectal, lung, ovarian, pancreas, and thyroid carcinomas. Principal Findings: We detected the previously reported mutations in 6/ 13 (46{\%}) blue naevi. Changes affecting Q209 were not found in any of the other tumors. Our data indicate that the occurrence of GNAQ mutations display a unique pattern being present in a subset of melanocytic tumors but not in malignancies of glial, epithelial and stromal origin analyzed in this study.",
author = "Simona Lamba and Lara Felicioni and Fiamma Buttitta and Bleeker, {Fonnet E.} and Sara Malatesta and Vincenzo Corbo and Aldo Scarpa and Monica Rodolfo and Margaret Knowles and Milo Frattini and Antonio Marchetti and Alberto Bardelli",
year = "2009",
month = "8",
day = "31",
doi = "10.1371/journal.pone.0006833",
language = "English",
volume = "4",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Mutational profile of GNAQQ209 in human tumors

AU - Lamba, Simona

AU - Felicioni, Lara

AU - Buttitta, Fiamma

AU - Bleeker, Fonnet E.

AU - Malatesta, Sara

AU - Corbo, Vincenzo

AU - Scarpa, Aldo

AU - Rodolfo, Monica

AU - Knowles, Margaret

AU - Frattini, Milo

AU - Marchetti, Antonio

AU - Bardelli, Alberto

PY - 2009/8/31

Y1 - 2009/8/31

N2 - Background: Frequent somatic mutations have recently been identified in the ras-like domain of the heterotrimeric G protein α-subunit (GNAQ) in blue naevi 83%, malignant blue naevi (50%) and ocular melanoma of the uvea (46%). The mutations exclusively affect codon 209 and result in GNAQ constitutive activation which, in turn, acts as a dominant oncogene. Methodology: To assess if the mutations are present in other tumor types we performed a systematic mutational profile of the GNAQ exon 5 in a panel of 922 neoplasms, including glioblastoma, gastrointestinal stromal tumors (GIST), acute myeloid leukemia (AML), blue naevi, skin melanoma, bladder, breast, colorectal, lung, ovarian, pancreas, and thyroid carcinomas. Principal Findings: We detected the previously reported mutations in 6/ 13 (46%) blue naevi. Changes affecting Q209 were not found in any of the other tumors. Our data indicate that the occurrence of GNAQ mutations display a unique pattern being present in a subset of melanocytic tumors but not in malignancies of glial, epithelial and stromal origin analyzed in this study.

AB - Background: Frequent somatic mutations have recently been identified in the ras-like domain of the heterotrimeric G protein α-subunit (GNAQ) in blue naevi 83%, malignant blue naevi (50%) and ocular melanoma of the uvea (46%). The mutations exclusively affect codon 209 and result in GNAQ constitutive activation which, in turn, acts as a dominant oncogene. Methodology: To assess if the mutations are present in other tumor types we performed a systematic mutational profile of the GNAQ exon 5 in a panel of 922 neoplasms, including glioblastoma, gastrointestinal stromal tumors (GIST), acute myeloid leukemia (AML), blue naevi, skin melanoma, bladder, breast, colorectal, lung, ovarian, pancreas, and thyroid carcinomas. Principal Findings: We detected the previously reported mutations in 6/ 13 (46%) blue naevi. Changes affecting Q209 were not found in any of the other tumors. Our data indicate that the occurrence of GNAQ mutations display a unique pattern being present in a subset of melanocytic tumors but not in malignancies of glial, epithelial and stromal origin analyzed in this study.

UR - http://www.scopus.com/inward/record.url?scp=69949119638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949119638&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0006833

DO - 10.1371/journal.pone.0006833

M3 - Article

C2 - 19718445

AN - SCOPUS:69949119638

VL - 4

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e6833

ER -